73 days ago
Actually it is an academic who has a long history in clinical trial data supervision and whose work in exposing malpractice has featured, inter alia, in Private Eye. The company in question is Hemogenyx (HEMO) where I think I owe it a minor apology but it owes Mr. Market an even greater one